HIV drug Aptivus gains new indication approval for kids
June 26, 2008
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
